Hisashi Tanaka
Hirosaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Cyclical Hemoptysis in a Patient With Right Lower Lobe Opacity.
Journal: CHEST pulmonary
Published: August 04, 2026
DIAGNOSIS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS BASED ON RENAL PATHOLOGICAL FINDINGS WITHOUT ASTHMA
Journal: Arerugi = [Allergy]
Published: April 12, 2026
Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance.
Journal: Anticancer research
Published: February 28, 2026
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study.
Journal: Translational lung cancer research
Published: February 20, 2026
Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study.
Journal: Translational lung cancer research
Published: February 09, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trial.
Journal: American journal of respiratory and critical care medicine
Published: January 25, 2026
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 11, 2026
Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 05, 2025
Reversible ST-T Segment Changes Induced by Anamorelin: A Case Report.
Journal: Respirology case reports
Published: August 24, 2025
Efficacy and safety of immune checkpoint inhibitors in advanced non-small cell lung cancer with idiopathic interstitial pneumonia or interstitial lung abnormalities: NJLCG2301.
Journal: Translational lung cancer research
Published: July 17, 2025
J-REGISTER: real-world study of Japanese patients with EGFR mutation-positive NSCLC treated with first-line afatinib.
Journal: Future oncology (London, England)
Published: June 07, 2025
Last Updated: 09/26/2026